DermTech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of DermTech generated cash of -$76,979,000, which is more than the previous year. Cash used in financing activities reached the amount of $6,079,000 last year. Net change in cash is therefore -$41,016,000.
Cash Flow
| 2017 | 2.19K | 0 | 6.36K |
|---|---|---|---|
| 2018 | -373.39K | -145.18M | 11.12M |
| 2019 | -17.79M | -210K | 28.62M |
| 2020 | -28.68M | -41.34M | 78.89M |
| 2021 | -62.10M | -12.51M | 230.27M |
| 2022 | -95.26M | -4.31M | 917K |
| 2023 | -76.97M | 29.86M | 6.07M |
DMTK Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 77.75M | 179.90M | 24.24M | 15.37M | 4.75M | 25K | 16.44K |
Operating activities | |||||||
Net income | -100.88M | -116.68M | -78.33M | -35.24M | -19.68M | 856.40K | -60 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 5.84M | 4.46M | 2.29M | 486K | 89K | 0 | 0 |
Stock-based compensation expense | 18.56M | 18.93M | 13.27M | 4.96M | 1.30M | 0 | 0 |
| Deferred income tax benefit | 18.56M | 18.93M | 13.27M | 4.96M | 1.30M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 1.58M | -325K | -2.36M | -800K | -100K | 0 | 0 |
Inventories | 753K | -1.27M | -376K | -69K | 5K | 0 | 0 |
Accounts payable | -1.84M | 1.88M | 4.33M | 827K | 1.33M | 26.35K | 2.25K |
Cash generated by operating activities | -76.97M | -95.26M | -62.10M | -28.68M | -17.79M | -373.39K | 2.19K |
Investing activities | |||||||
Purchases Of Investments | -34.39M | -31.49M | -48.09M | -41.70M | 0 | -145.18M | 0 |
Investments In Property Plant And Equipment | -902K | -3.30M | -2.72M | -1.83M | -210K | 0 | 0 |
Acquisitions Net | 960K | -650K | -123K | 39.50M | 0 | 0 | 0 |
Cash generated by investing activities | 29.86M | -4.31M | -12.51M | -41.34M | -210K | -145.18M | 0 |
Financing activities | |||||||
Common Stock Issued | 6.19M | 22K | 230.44M | 42.99M | 19.80M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -171K | -9K | 0 | 0 | 0 |
Cash used in financing activities | 6.07M | 917K | 230.27M | 78.89M | 28.62M | 11.12M | 6.36K |
Net Change In Cash | -41.01M | -98.66M | 155.65M | 8.87M | 10.62M | 424.94K | 8.55K |
Cash at end of period | 36.74M | 81.24M | 179.90M | 24.24M | 15.37M | 449.94K | 25K |
| Data source | Data source | Data source | Data source | Data source | Data source |